Global Market for Cloud Computing in Pharmaceutical Research and Development fueled by Rise in Clinical Trials

Published Date : Mar 21, 2016

Albany, New York, March 21, 2016: announces the addition of a new research report titled “Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-generation DNA Sequencing and Clinical Trials Data Management.” The 39-page research publication offers clients sharp insight into the major applications of cloud computing in the research, development, and sales effectiveness segments of the pharmaceutical industry. The study offers a better understanding about various technological concepts in cloud computing, including cloud computing deployment models, service models, and major stakeholders.

The advent of cloud computing has managed to transform the invention, deployment updating, development, and maintenance of information technology services. The considerable rise in the power of modern machines has resulted in the decline of the per-unit cost of computing. At the same time, the cost of managing infrastructure within the information technology sector has increased drastically. This can be attributed to the rising penetration of systems within the organizations, which has, in turn, raised the complexity of the overall infrastructure. Cloud computing offers to not only deliver new as well as existing functionalities of IT but also promises a considerable reduction in the cost of deploying these functionalities.

The cloud computing market in pharmaceutical research and development comprises core technologies, cloud computing deployment models, cloud computing service models, and stakeholders. By core technologies, the market for cloud computing in pharmaceutical research and development is segmented into multi-tenancy, virtualization, and web services. On the basis of cloud computing service models, the market is divided into platform as a service (PaaS), infrastructure as a service (IaaS), and software as a service (SaaS). The major stakeholders in the cloud computing market in pharmaceutical research and development include providers, consumers and end users, enablers, and regulators.

For Sample Copy, click here:

The vendor landscape of the global cloud computing market includes innovative companies, technology providers, and established players. The companies studied in the research report are Microsoft,, Innovative Companies, Apache, EMC, International Business Machines Corporation (IBM), Google, and

The report on the cloud computing market in pharmaceutical research and development lists the benefits and restraints to using cloud-based services. According to the report, the advantages of the cloud include immediate access to resources, cost savings, scalability of services, lower barriers to innovation, and new classes of services and applications. On the flip side, the disadvantages of the cloud include data location and privacy, security, level of service and system availability, dependence on the internet, and migration of current applications.

Cloud computing in the pharmaceutical sector can be used in applications such as next-generation sequencing, biomedical cloud, in silico research, bioinformatics and genomics, management of clinical trials, and information dissemination. Biomedical cloud applications include communication with private clouds, adequate security measures, data transfer, on-demand scalability, and interaction with other clouds.

To order report Call Toll Free: 866-997-4948 or send an email on